Print

Endologix Inc. Appoints Charles Love Vice President of Clinical Affairs  
10/1/2012 9:49:57 AM

IRVINE, Calif., Oct. 1, 2012 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has appointed Charles Love to the position Vice President of Clinical Affairs. Mr. Love will be responsible for overseeing all Endologix U.S. and international clinical trials and will report to John McDermott, President and Chief Executive Officer. Janet Fauls, previously Vice President of Regulatory and Clinical Affairs, will maintain responsibility for overseeing Regulatory Affairs as the Company prepares for multiple upcoming potential regulatory milestones for its product pipeline.
//-->